Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (34)

« Back to Publications

Autoantibodies as drivers of neuropathic pain.

Farah A. et al, (2026), Trends Mol Med, 32, 101 - 104

Understanding sensory abnormalities in fibromyalgia through autoantibodies

Themistocleous AC. et al, (2025), Brain, 148, 3792 - 3794

Specific overexpression of contactin-associated protein-like 2 and its effects on pain-related behaviour in mice

Tseng M. et al, (2025), PAIN Reports, 10, e1309 - e1309

A role for leucine-rich, glioma inactivated 1 in regulating pain sensitivity

Farah A. et al, (2025), Brain, 148, 1001 - 1014

Immunotherapy‐Resistant Neuropathic Pain and Fatigue Predict Quality‐of‐Life in Contactin‐Associated Protein‐Like 2 Antibody Disease

Ceronie B. et al, (2025), Annals of Neurology, 97, 521 - 528

Antibody-mediated autoimmunity in symptom-based disorders: position statement and proceedings from an international workshop

Mountford R. et al, (2024), PAIN Reports, 9, e1167 - e1167

A role for pathogenic autoantibodies in small fiber neuropathy?

Daifallah O. et al, (2023), Frontiers in Molecular Neuroscience, 16

Corrigendum: A role for pathogenic autoantibodies in small fiber neuropathy?

Daifallah O. et al, (2023), Front Mol Neurosci, 16

The structure of sensory afferent compartments in health and disease

Middleton SJ. et al, (2022), Journal of Anatomy, 241, 1186 - 1210

Leucine‐Rich Glioma‐Inactivated 1 versus Contactin‐Associated Protein‐like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons

Ramanathan S. et al, (2021), Annals of Neurology, 90, 683 - 690

Addressing the gender pain gap

Dawes JM. and Bennett DL., (2021), Neuron, 109, 2641 - 2642

007 Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies

Ramanathan S. et al, (2021), Oral abstracts, A3.2 - A4

Autism Spectrum Disorders: Multiple Routes to, and Multiple Consequences of, Abnormal Synaptic Function and Connectivity

Carroll L. et al, (2021), The Neuroscientist, 27, 10 - 29

Comprehensive analysis of long noncoding RNA expression in dorsal root ganglion reveals cell-type specificity and dysregulation after nerve injury

Baskozos G. et al, (2019), Pain, 160, 463 - 485

Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability

Dawes JM. et al, (2018), Neuron, 97, 806 - 822.e10

Load More